SCHEMBL9457075

SCHEMBL9457075

CCCCC/C=C\C/C=C\CCCCCCC[C@@H](O)CC(=O)O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 4/20 0.72
▸ FFAR1 O14842 4/20 0.62
▸ FFAR4 Q5NUL3 2/20 0.62
▸ ALDH1A1 P00352 5/20 0.61
▸ PPARG P37231 5/20 0.61
▸ F7 P08709 4/20 0.61
▸ F3 P13726 4/20 0.61
▸ PPARD Q03181 4/20 0.61
▸ PPARA Q07869 4/20 0.61
▸ KDM4E B2RXH2 2/20 0.61
▸ LMNA P02545 2/20 0.61
▸ CYP3A4 P08684 2/20 0.61
▸ CYP19A1 P11511 2/20 0.61
▸ FABP4 P15090 2/20 0.61
▸ HPGD P15428 2/20 0.61
▸ ALOX15 P16050 2/20 0.61
▸ PTGS1 P23219 2/20 0.61
▸ AKR1C3 P42330 2/20 0.61
▸ NR4A2 P43354 2/20 0.61
▸ HSD17B10 Q99714 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9457081 1.00 GPR84 (0.72) GPR84FFAR1FFAR4ALDH1A1PPARG
SCHEMBL9457086 1.00 GPR84 (0.72) GPR84FFAR1FFAR4ALDH1A1PPARG
SCHEMBL8604202 1.00 GPR84 (0.72) GPR84FFAR1FFAR4ALDH1A1PPARG
SCHEMBL8603623 0.95 GPR84 (0.79) GPR84FFAR1FFAR4PPARGF7
SCHEMBL9456915 0.95 GPR84 (0.79) GPR84FFAR1FFAR4PPARGF7
SCHEMBL9456908 0.95 GPR84 (0.79) GPR84FFAR1FFAR4PPARGF7
SCHEMBL9457258 0.95 GPR84 (0.79) GPR84FFAR1FFAR4PPARGF7
SCHEMBL17583528 0.95 GPR84 (0.79) GPR84FFAR1FFAR4PPARGF7
SCHEMBL9457267 0.95 GPR84 (0.79) GPR84FFAR1FFAR4PPARGF7
SCHEMBL8603618 0.95 GPR84 (0.79) GPR84FFAR1FFAR4PPARGF7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5246960-A Used to treat obesity, hyperlipaemia, atherosclerosis and arteriosclerosis HOFFMANN-LA ROCHE INC. (US) 1993-09-21 — — US disclosed
US-5175186-A Inhibits pancreas lepase and useful agent in treatment of obesity, hyperlipemia, atherosclerosis and arteriosclerosis HOFFMANN-LA ROCHE INC. (US) 1992-12-29 — — US disclosed
EP-0185359-B1 OXETANONE F. HOFFMANN-LA ROCHE AG (CH) 1991-12-04 — — EP disclosed
US-4931463-A PANCREAS LIPASE INHIBITORS HOFFMANN-LA ROCHE INC. (US) 1990-06-05 — — US disclosed
EP-0185359-A2 Oxetanone F. HOFFMANN-LA ROCHE AG (CH) 1986-06-25 — — EP disclosed
Send feedback